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Pulmonary artery diseases encompass a wide spectrum of pathology from acute embolic disease to chronic conditions, such as pulmonary hypertension. The first line treatment for pulmonary embolism is anticoagulation. However sub-massive or massive pulmonary embolism are associated with a poor outcome and therefore there is growing evidence for catheter directed thrombolysis using a variety of techniques, such as ultrasound assisted approaches. In selected patient with chronic pulmonary embolism endovascular therapy can be indicated to potentially avoid pulmonary hypertension as a long-term sequela. Both, primary and secondary forms of pulmonary hypertension are associated with a decreased quality of life and high mortality. Innovative treatment approaches are warranted in the near future to treat pulmonary hypertension. Advanced imaging work-up, such as gadolinium enhanced MRI or post-processing methods, such as computational fluid dynamics may enable risk stratification as well as non-invasive disease severity assessment, thereby facilitating selection of patients for more aggressive treatment approaches, specifically endovascular therapy in addition to drug-based regimens.
The first part of this topical issue is including review papers from leading institutions and authors worldwide describing the current literature as well as future perspectives based on the authors' experience and expertise. The first paper by Rengier et al. discusses evolving imaging techniques for diagnosis and follow-up of pulmonary hypertension [1] . The second manuscript by Rajiah et al. focuses on multi-energy CT for the assessment of pulmonary vasculature [2] whereas the third manuscript by Aziz et al. elaborates around MRI for the evaluation of the pulmonary vasculature [3] . The next paper from Zucker describes the value of cross-sectional imaging in the setting of congenital pulmonary artery anomalies [4] . The manuscript from Kalra-Lall and colleagues discussed pulmonary artery aneurysms and pseudoaneurysms [5] . The paper from Javed and Sista deals with endovascular therapeutic options for massive and submassive pulmonary embolism [6] . Embolization techniques and outcomes for the treatment of pulmonary arteriovenous malformations are discussed based on extensive institutional experience in the review paper from Tellapuri et al. [7] . Imaging characteristics of pulmonary artery sarcoma and their surgical treatment is described in the paper form Wyler von Ballmoos and colleagues [8] .
The second part of this topical issue is encompassing high quality original research papers dealing with different pulmonary artery disease entities including pulmonary artery reconstruction, pulmonary hypertension and endovascular pulmonary valve implantation. The paper from Zucker et al. investigates the use of CT angiography for preoperative planning of pulmonary artery reconstruction in pediatric patients and demonstrates the value of iodine maps in this context [9] . Doppler estimates of pulmonary vascular resistance were used to differentiate two different types of pulmonary hypertension in the heart failure population in the article by Venkateshvaran [10] . Dasatinib induced pulmonary arterial hypertension was investigated in a study by Toya et al. using clinical and imaging parameters [11] . The study of Liu et al. assessed the role of two-dimensional speckle tracking echocardiography in pre-capillary pulmonary hypertension [12] . The role of MR imaging for Tetralogy patients undergoing transcatheter pulmonary valve implantation was the focus of the research manuscripts from Leonardi et al. [13] and from Ebel et al. [14] .
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The papers of this topical issue of The International Journal of Cardiovascular Imaging are not intended to represent the entire field of pulmonary artery diseases. Though they represent a fine selection of strong review and original research articles, offering readers of the journal an opportunity to get a robust overview of imaging and interventions for a variety of pulmonary diseases. A fundamental understanding of this will be needed in the coming decades as research is conducted to develop and validate new therapies for this important disease spectrum.
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